Cardiovascular Risk Factors Involved in Hemorrhagic Transformation After Intravenous Thrombolytic Therapy in Patients with Acute Ischemic Stroke
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms262010186 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ileana Neacă und 6 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Hauptthemen laut MEDLINE: Ischemic Stroke, Thrombolytic Therapy, Fibrinolytic Agents, Cerebral Hemorrhage. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 161 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, University of Medicine and Pharmacy of Craiova, Romania.
Themen: Schlaganfall
Abstract (Originalsprache)
In line with AHA/ASA guidance, intravenous alteplase has served as the standard first-line reperfusion treatment in acute ischemic stroke (AIS). Hemorrhagic transformation (HT) is a common spontaneous complication after thrombolytic therapy for AIS with increased mortality. Restoration of flow in an occluded artery can precipitate blood–brain barrier breakdown and heighten the risk of HT. However, the pathogenesis of HT is multifactorial, and identifying patients at high risk after recanalization therapy (RT) has a defining role in ensuring optimal treatment. At the same time, it is still under debate how these patients can best be identified based on clinical and biological characteristics. Preventing HT will become increasingly essential. In this review, our primary objective was to identify research focused on the cardiovascular risk factors predicting HT after AIS treated with thrombolytics, as this may help develop targeted treatment strategies and diminish the risk of HT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Sanocare Medical Center Craiova, 200061 Craiova, Romania.
- Department of Pathophysiology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
- Clinical Emergency County Hospital of Craiova, 200642 Craiova, Romania.
ORCID-Profile: Iulia Tudorașcu, Suzana Dănoiu, Despina Manuela Toader
Förderung
- University of Medicine and Pharmacy of Craiova
- University of Medicine and Pharmacy of Craiova, Romania
Zitieren
APA
Neacă, I., Negroiu, C. E., Tudorașcu, I., Dănoiu, R., Godeanu, S., Dănoiu, S., & Toader, D. M. (2025). Cardiovascular Risk Factors Involved in Hemorrhagic Transformation After Intravenous Thrombolytic Therapy in Patients with Acute Ischemic Stroke. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262010186
Vancouver
Neacă I, Negroiu CE, Tudorașcu I, Dănoiu R, Godeanu S, Dănoiu S, et al. Cardiovascular Risk Factors Involved in Hemorrhagic Transformation After Intravenous Thrombolytic Therapy in Patients with Acute Ischemic Stroke. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262010186
BibTeX
@article{Neac2025,
author = {Neacă, Ileana and Negroiu, Cristina Elena and Tudorașcu, Iulia and Dănoiu, Raluca and Godeanu, Sânziana and Dănoiu, Suzana and Toader, Despina Manuela},
title = {Cardiovascular Risk Factors Involved in Hemorrhagic Transformation After Intravenous Thrombolytic Therapy in Patients with Acute Ischemic Stroke},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms262010186}
}
EUVIMED